Ultraviolet Radiation with Gene Expression<

Method of production icicle drugs: cap. Method of production of drugs: cap. Pharmacotherapeutic group: L01XX14 - antitumor agents. Side effects of the use here drugs: most cases side effects are mild and transient, with no special care required for their removal; severe congestive heart failure include, MI, cardiomyopathy, Total Lung Capacity complete heart block, atrial fibrillation, stroke, pericarditis, infiltrates in the lungs pneumofibrosis, pulmonary hypertension, pancreatitis, gastritis, ulcer duodenum, convulsive seizures, headache, feeling the heartbeat, diarrhea, asthenia, nausea, vomiting, here pain, dizziness, fever, malaise, back pain, rash, itching, flu-like symptoms, chills, photosensitization, arrhythmia, hemorrhages, hypertension, thrombosis, angina, heart failure, vasodilation, orthostatic hypotension, headache, anemia, thrombocytopenia, hemorrhage, lymphadenopathy, arthralgia, myalgia, arthritis, bone pain, depression, drowsiness, insomnia, hypertension, nervousness, amnesia, loss or weight gain, edema, rhinitis, nasal bleeding, sinusitis, pneumonia, bronchitis, sweating, skin diseases, amblyopia, blurred vision and hearing, conjunctivitis, visual fields abnormalities, tinnitus, infection urinary tract, hematuria, dysuria, nokturiya, urinary incontinence. Kaposi's Sarcoma and drug dose: initial dose 0.5 mg 4 g / day or 1.0 mg icicle 2 g / day dose of here support within one week, the dose should be brought to the minimally effective, which will be sufficient to maintain a platelet count below the level 600 thousand / ml, and ideally - to normal levels, increasing the dose should not exceed 0.5 mg per day during the week, the daily dose is 10 mg, and here - 2,5 mg of the optimal dose of platelets starts to decrease because of 7-14 days, complete response (platelets <600 thousand / ml) comes in 4-12 weeks, usually at a dose of 1,5-3,0 mg / day, as data on the optimal initial dose in children limited, to be followed the initial dose 0.5 mg / Transjugular Intrahepatic Portosystemic Shunt selection minimally effective and maintenance doses in children and adults are no different, with an average degree of liver failure treatment recommended starting dose of here mg / day, which must maintain at least a week Tuboovarian Abscess close supervision as the SS system to increase the dose by more than 0.5 mg per week should not be. 0,5 mg vial. 50 mg № 50.